Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | BRD4 | O60885 | 1/20 | 0.30 |
| ▸ | TAF1 | P21675 | 1/20 | 0.30 |
| ▸ | CECR2 | Q9BXF3 | 1/20 | 0.30 |
| ▸ | BRD9 | Q9H8M2 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24848879 | 0.79 | CYP2D6 (0.30) | HRH3CYP2D6KCNH2 | |
| SCHEMBL22404388 | 0.78 | HRH3 (0.37) | HRH3CYP2D6KCNH2CHRNA7MEN1 | |
| SCHEMBL17886940 | 0.78 | HRH3 (0.36) | HRH3CYP2D6KCNH2BRD4TAF1 | |
| SCHEMBL24848878 | 0.75 | — | — | |
| SCHEMBL1306676 | 0.74 | HRH3 (0.41) | HRH3CYP2D6KCNH2MEN1KMT2A | |
| SCHEMBL803511 | 0.72 | L3MBTL3 (0.38) | HRH3CYP2D6KCNH2CHRNA7ALDH1A1 | |
| SCHEMBL22753502 | 0.71 | HRH3 (0.36) | HRH3CYP2D6KCNH2BRD4TAF1 | |
| SCHEMBL19652094 | 0.71 | HRH3 (0.41) | HRH3CYP2D6KCNH2MEN1KMT2A | |
| SCHEMBL19652096 | 0.71 | HRH3 (0.41) | HRH3CYP2D6KCNH2MEN1KMT2A | |
| SCHEMBL11991385 | 0.70 | HRH3 (0.37) | HRH3CYP2D6KCNH2CHRNA7MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230002348-A1 | GLP-1 Receptor Agonist and Use Thereof | ILDONG PHARMACEUTICAL CO., LTD. (KR) | 2023-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230002348-A1 | GLP-1 Receptor Agonist and Use Thereof | GLP1R, GIPR, GPR119 | HRH3 1856/4885CYP2D6 1273/4885KCNH2 1095/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.